GlassScriptPhysician profile
Lee M Shangold
NPI 1902887730
$6,684.38
in general payments reported to CMS, 2019-2025
29 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what 78% of Sleep Medicine (Otolaryngology) providers received nationally (typical 2025 total: $509).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $172 · 2021: $1,465 · 2022: $692 · 2023: $1,236 · 2024: $1,251 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,839.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,195.92 | 2021-2025 | Inspire |
| Optinose US, INC. | $644.38 | 2019-2025 | |
| Stryker Corporation | $430.18 | 2019-2025 | Clarifix, Hemopore |
| Glaxosmithkline, LLC. | $394.20 | 2021-2025 | Nucala |
| Axsome Therapeutics, INC. | $278.87 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $246.77 | 2019-2025 | Xywav |
| Regeneron Healthcare Solutions, INC. | $214.29 | 2023-2025 | Dupixent |
| Itamar Medical INC | $160.07 | 2022-2023 | Watchpatone |
| Harmony Biosciences LLC | $148.40 | 2020-2024 | Wakix |
| Lilly USA, LLC | $137.19 | 2025 | Zepbound |
| Philips North America LLC | $94.67 | 2019 | |
| Pfizer INC. | $83.94 | 2024-2025 | |
| Medtronic, INC. | $81.17 | 2023-2024 | Novapak, Sinuva, Propel |
| Genentech USA, INC. | $75.64 | 2023-2025 | Xolair |
| Zoll Respicardia, INC. | $68.91 | 2024 | Remede System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $62.25 | 2019-2025 | |
| Integra Lifesciences Corporation | $61.81 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Hikma Pharmaceuticals USA | $50.50 | 2024 | Ryaltris |
| Aerin Medical INC. | $34.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $32.95 | 2025 | Xhance |
| Merck Sharp & Dohme LLC | $29.39 | 2023 | |
| Grifols USA, LLC | $28.48 | 2025 | Xembify |
| Intersect Ent, INC. | $25.34 | 2019 | |
| Pharming Healthcare, INC. | $23.25 | 2025 | Ruconest |
| Acelrx Pharmaceuticals, INC. | $19.41 | 2020 | |
| Amgen INC. | $17.60 | 2022 | |
| Aytu Biopharma, INC. | $15.14 | 2023 | Karbinal |
| 3b Medical, INC. | $14.83 | 2025 | Luna |
| Shire North American Group INC | $14.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Shangold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.